A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: Analysis from the EVEREST trial

Heart Failure Reviews

Volumn 17, Issue 3, 2012, Pages 485-509

  Gheorghiade, Mihai ^a   Pang, Peter S ^a   Ambrosy, Andrew P ^a   Lan, Gloria ^b   Schmidt, Philip ^a   Filippatos, Gerasimos ^c   Konstam, Marvin ^d   Swedberg, Karl ^e   Cook, Thomas ^f   Traver, Brian ^g   Maggioni, Aldo ^h   Burnett, John ⁱ   Grinfeld, Liliana ^j   Udelson, James ^d   Zannad, Faiez ^k  

^a NORTHWESTERN UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g UNIVERSITY OF WISCONSIN MADISON   (United States)

^h ANMCO RESEARCH CENTER   (Italy)

ⁱ MAYO CLINIC   (United States)

^j HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^k INSERM   (France)

more..

Author keywords

Acute heart failure; Characterization; Mortality; Patient profiles; Re hospitalization

Indexed keywords

ALBUMIN; ALDOSTERONE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ARGIPRESSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INOTROPIC AGENT; NEUROHORMONE; NITROGEN; PLACEBO; POTASSIUM; SODIUM; SPIRONOLACTONE; TOLVAPTAN; UREA;

ACUTE HEART FAILURE; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BREATHING DISORDER; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DRUG USE; DYSPNEA; FEMALE; FOOT EDEMA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; JUGULAR VEIN DISTENTION; LABORATORY DIAGNOSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; ORTHOPNEA; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PHYSICAL EXAMINATION; POTASSIUM BLOOD LEVEL; QRS COMPLEX; RETROSPECTIVE STUDY; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; VEIN DISEASE; WEIGHT REDUCTION;

BENZAZEPINES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; NEUROTRANSMITTER AGENTS; PATIENT READMISSION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, VASOPRESSIN; RETROSPECTIVE STUDIES;

EID: 84861553275     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-011-9280-0     Document Type: Article

References (27)

1. Bueno H, Ross JS, Wang Y, Chen J, Vidan MT, Normand SL, Curtis JP, Drye EE, Lichtman JH, Keenan PS, Kosiborod M, Krumholz HM (2010) Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA 303:2141-2147
2. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, Stough WG, Yancy CW, Young JB, Fonarow GC (2006) Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296:2217-2226
3. Jencks SF, Williams MV, Coleman EA (2009) Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 360:1418-1428
4. Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Pieper K, Sun J-L, Yancy CW, Young J (2007) Association Between Performance Measures and Clinical Outcomes for Patients Hospitalized with Heart Failure. JAMA 297:61-70
5. Fonarow GC, Peterson ED (2009) Heart failure performance measures and outcomes: real or illusory gains. JAMA 302:792-794
6. Pang PS, Komajda M, Gheorghiade M (2010) The current and future management of acute heart failure syndromes. Eur Heart J 31:784-793
7. Orzag P (2009) New Study on Hospital Readmissions [Blog] http://www.whitehouse.gov/omb/blog/09/04/08/NewStudyonHospitalReadmissions/. Accessed 9 June 2009
8. Hernandez AF, Greiner MA, Fonarow GC, Hammill BG, Heidenreich PA, Yancy CW, Peterson ED, Curtis LH (2010) Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA 303:1716-1722
9. Gheorghiade M, Orlandi C, Burnett JC, Demets D, Grinfeld L, Maggioni A, Swedberg K, Udelson JE, Zannad F, Zimmer C, Konstam MA (2005) Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). J Card Fail 11:260-269
10. O'Connor CM, Miller AB, Blair JE, Konstam MA, Wedge P, Bahit MC, Carson P, Haass M, Hauptman PJ, Metra M, Oren RM, Patten R, Pina I, Roth S, Sackner-Bernstein JD, Traver B, Cook T, Gheorghiade M (2010) Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J 159:841-849, e841
11. Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C (2007) For the efficacy of vasopressin antagonism in heart failure outcome study with Tolvaptan I. Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure: The EVEREST Outcome Trial. JAMA 297:1319-1331
12. Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C (2007) Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA 297:1332-1343
13. Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB (2007) Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 50:768-777
14. Harjola VP, Follath F, Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Hochadel M, Komajda M, Lopez-Sendon JL, Ponikowski P, Tavazzi L (2010) Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. Eur J Heart Fail 12:239-248
15. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC (2006) Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 47:76-84
16. Metra M, Gheorghiade M, Bonow RO, Dei Cas L (2010) Postdischarge assessment after a heart failure hospitalization: the next step forward. Circulation 122:1782-1785
17. Gheorghiade M, Bonow RO (2010) Heart failure: Early follow-up after hospitalization for heart failure. Nat Rev Cardiol 7:422-424
18. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ (2005) Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293:572-580
19. Klein L, Massie BM, Leimberger JD, O'Connor CM, Pina IL, Adams KF, Califf RM, Gheorghiade M (2008) Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the outcomes of a prospective trial of intravenous milrinione for exacerbation of chronic heart failure (OPTIME-CHF). Circulat Heart Fail 1:25-33
20. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV (2003) Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290:2581-2587
21. Adams JKF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149:209-216
22. Bonow RO (2009) Measuring quality in heart failure: do we have the metrics? Circulat Cardiovasc Quality Outcomes 1:9-11
23. Ross JS, Mulvey GK, Stauffer B, Patlolla V, Bernheim SM, Keenan PS, Krumholz HM (2008) Statistical models and patient predictors of readmission for heart failure: a systematic review. Arch Intern Med 168:1371-1386
24. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J (2003) The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24:442-463
25. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL, Ponikowski P, Tavazzi L (2006) EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27:2725-2736
26. Fonarow GC (2003) The acute decompensated heart failure national registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 4 (Suppl 7):S21-S30
27. Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Yancy CW, Young J (2004) Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design. Am Heart J 148:43-51